A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease
Condition(s):Hyperuricemia; Hypouricemia, RenalLast Updated:March 15, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Hyperuricemia; Hypouricemia, RenalLast Updated:March 15, 2024Not yet recruiting
Condition(s):Epilepsy in Children; Epilepsy IntractableLast Updated:March 15, 2024Recruiting
Condition(s):Nosocomial Infection; Nosocomial Pneumonia; Tracheobronchitis; Mechanical Ventilation Complication; Endotracheal IntubationLast Updated:March 15, 2024Not yet recruiting
Condition(s):Peripheral Arterial DiseaseLast Updated:March 15, 2024Recruiting
Condition(s):Non-small Cell Lung Cancer Stage IIIB/IVLast Updated:March 15, 2024Recruiting
Condition(s):Pancreatic NeoplasmsLast Updated:March 15, 2024Recruiting
Condition(s):Palliative MedicineLast Updated:March 18, 2024Withdrawn
Condition(s):HealthyLast Updated:March 15, 2024Not yet recruiting
Condition(s):Dermal FillersLast Updated:March 15, 2024Completed
Condition(s):Epidural Catheterization; Thoracic; Procedural PainLast Updated:March 15, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.